mo yang

Prof. mo yang


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Thrombosis Research
Verified
Journal Article
Closed access
YZYujiao Zhang
Yujiao Zhang
XZXiaoyuan Zeng
Xiaoyuan Zeng
YJYingying Jiao
Yingying Jiao
ZLZongpeng Li
Zongpeng Li
QLQifa Liu
Qifa Liu
MYmo yang
mo yang

20 February 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
BZBin Zhang
Bin Zhang
KZKuan Zeng
Kuan Zeng
RGRui-Cong Guan
Rui-Cong Guan
HJHui-Qi Jiang
Hui-Qi Jiang
YQYong-Jia Qiang
Yong-Jia Qiang
YYYanqi Yang
Yanqi Yang
Macrophages play an important role in the progression of sporadic acute type A aortic dissection (ATAAD). The aim of this study was to characterize the cellular heterogeneity of macrophages in ATAAD tissues by scRNA-seq. Ascending aortic wall tissue from six ATAAD patients and three heart transplant donors was assessed by scRNA-seq and then analyzed and validated by various bioinformatic algorithms and histopathology experiments. The results revealed that the proportion of macrophages in ATAAD tissues (24.51%) was significantly higher than that in normal tissues (13.69%). Among the six macrophage subclusters, pro-inflammatory macrophages accounted for 14.96% of macrophages in the AD group and 0.18% in the normal group. Chemokine- and inflammation-related genes (CCL2, CCL20, S100A8, and S100A9) were expressed more intensively in macrophages in ATAAD tissue than in those in normal tissue. Additionally, intercellular communication analysis and transcription factor analysis indicated the activation of inflammation and degradation of the extracellular matrix in ATAAD tissue. Finally, immunohistochemistry, immunofluorescence, and Western blot experiments confirmed the overexpression of macrophage marker genes (CD68 and CD163) and matrix metalloproteinases (MMP9 and MMP2) in ATAAD tissue. Collectively, our study provides a preliminary evaluation of the role of macrophages in ATAAD, and the results could aid in the development of therapeutic options in the future.

2 June 2020 in Investigational New Drugs
Verified
Journal Article
Closed access
PDF file
ZHZi-Wen Han
Zi-Wen Han
ZLZhi-Wu Lyv
Zhi-Wu Lyv
BCBin Cui
Bin Cui
YWYing-Ying Wang
Ying-Ying Wang
JCJun-Ting Cheng
Jun-Ting Cheng
HXHong-Wu Xin
Hong-Wu Xin

20 September 2019 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
XZXin Zhang
Xin Zhang
ZNZubiao Niu
Zubiao Niu
HQHongquan Qin
Hongquan Qin
JFJie Fan
Jie Fan
MWManna Wang
Manna Wang
QSQiang Sun
Qiang Sun
Though current pathological methods are greatly improved, they provide rather limited functional information. Cell-in-cell structures (CICs), arising from active cell–cell interaction, are functional surrogates of complicated cell behaviors within heterogeneous cancers. In light of this, we performed the subtype-based CIC profiling in human breast cancers by the “EML” multiplex staining method, and accessed their values as prognostic factors by Cox univariate, multivariate, and nomogram analysis. CICs were detected in cancer specimens but not in normal breast tissues. A total of five types of CICs were identified with one homotypic subtype (91%) and four heterotypic subtypes (9%). Overall CICs (oCICs) significantly associated with patient overall survival (OS) (P = 0.011) as an independent protective factor (HR = 0.423, 95% CI, 0.227–0.785; P = 0.006). Remarkably, three CICs subtypes (TiT, TiM, and MiT) were also independent prognostic factors. Among them, higher TiT, from homotypic cannibalism between tumor cells, predicted longer patient survival (HR = 0.529, 95% CI, 0.288–0.973; P = 0.04) in a way similar to that of oCICs and that (HR = 0.524, 95% CI, 0.286–0.962; P = 0.037) of heterotypic TiM (tumor cell inside macrophage); conversely, the presence of MiT (macrophage inside tumor cell) predicted a death hazard of 2.608 (95% CI, 1.344–5.063; P = 0.05). Moreover, each CIC subtype tended to preferentially affect different categories of breast cancer, with TiT (P < 0.0001) and oCICs (P = 0.008) targeting luminal B (Her2+), TiM (P = 0.011) targeting HR− (Her2+/HR− and TNBC), and MiT targeting luminal A (P = 0.017) and luminal B (Her−) (P = 0.006). Furthermore, nomogram analysis suggested that CICs impacted patient outcomes in contributions comparable (for oCICs, TiT, and TiM), or even superior (for MiT), to TNM stage and breast cancer subtype, and incorporating CICs improved nomogram performance. Together, we propose CICs profiling as a valuable way for prognostic analysis of breast cancer and that CICs and their subtypes, such as MiT, may serve as a type of novel functional markers assisting clinical practices.

14 November 2017 in Oncology Letters
Verified
Journal Article
Open access
PDF file
HWHan Wang
Han Wang
HWHua Wang
Hua Wang
ELEn‑Yu Liang
En‑Yu Liang
LZLi‑Xia Zhou
Li‑Xia Zhou
ZDZhan‑Ling Dong
Zhan‑Ling Dong
MYmo yang
mo yang
Cardiac toxicity has been the major concern when using doxorubicin (DOX) in cancer therapy. Thrombopoietin (TPO) protects cardiac cells from DOX‑induced cell damage; however, its molecular mechanism remains exclusive. The anti‑autophagic and anti‑apoptotic effects of TPO upon DOX treatment were studied in the cardiac H9C2 cell line, with bafilomycin A1 treatment as a positive control for autophagy inhibition. Cell viability was measured by Cell Counting Kit‑8 assay in different treatment groups. The mRNA and/or protein levels of apoptotic markers and autophagy‑associated factors were detected. The mean number of microtubule‑associated protein 1A/1B‑light chain 3 (LC3) puncta per cell was quantified to indicate autophagosomes and autolysosomes, of which the ones co‑stained with lysosomal‑associated membrane protein 1 were considered as autolysosomes. DOX treatment (5 µg/ml, 24 h) significantly impaired H9C2 cell viability compared with the control, while TPO pretreatment (10 ng/ml, 36 h) improved cell viability upon DOX treatment. DOX exposure markedly increased LC3 puncta in H9C2 cells, and TPO pretreatment reduced the number of autophagosomes, but showed no significant inhibitory effect on autolysosome formation. The autophagy inhibition by TPO upon DOX treatment was confirmed according to protein quantification of LC3‑II and nucleoporin 62. TPO also suppressed autophagy‑promoting protein Beclin‑1, and elevated the anti‑autophagic factors GATA‑binding protein‑4 and B cell lymphoma‑2. Furthermore, TPO reduced DOX‑induced apoptosis in H9C2 cells, as reflected by the amount changes of caspase‑3. Taken together, these results revealed that TPO has a protective role in H9C2 cells from DOX‑induced autophagy as well as apoptosis, and indicated that TPO may act as a cardioprotective drug in DOX‑treated patients.

27 April 2020 in Aging
Verified
Journal Article
Open access
LLLiang Li
Liang Li
CYChenju Yi
Chenju Yi
WXWenJie Xia
WenJie Xia
BHBihui Huang
Bihui Huang
SCShichao Chen
Shichao Chen
MYmo yang
mo yang
Thrombopoietin (TPO) is a growth factor for the megakaryocytic/platelet lineage. In this study, we investigated the expression of TPO and its receptor, c-Mpl, in the human central nervous system (CNS) and their roles after a neural insult. Our results demonstrate that both TPO and c-Mpl are expressed in the neurons of the human CNS. TPO was also detected in human cerebrospinal fluid. TPO was found to be neuroprotective in hypoxic-ischemic neonatal rat brain models. In these rat models, treatment with TPO reduced brain damage and improved sensorimotor functions. In addition, TPO promoted C17.2 cell proliferation through activation of the PI3K/Akt signaling pathway. Via the Bcl-2/BAX signaling pathway, TPO exerted an antiapoptotic effect by suppressing mitochondrial membrane potentials. Taken together, our results indicate that TPO is neuroprotective in the CNS.